Revance Therapeutics announces executive changes
Revance Therapeutics announced executive changes effective October 1, 2025: Kira Schwartz joined as Chief Legal Officer, bringing 20+ years from biotech firms; Nick Crowe was promoted from VP to Chief Operating Officer, overseeing global operations. These aim to streamline regulatory and supply chai
Revance Therapeutics announced executive changes effective October 1, 2025: Kira Schwartz joined as Chief Legal Officer, bringing 20+ years from biotech firms; Nick Crowe was promoted from VP to Chief Operating Officer, overseeing global operations. These aim to streamline regulatory and supply chain functions amid product launches.

Comments (0)
No comments yet. Be the first.